News

Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Atrial Fibrillation ...
PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.
A WIRRAL woman was diagnosed with incurable stage 4 breast cancer after her tumour was dismissed as her having "lumpy boobs" for ...
Vynca, a healthcare services and software company that cares for individuals with serious illnesses and complex needs, today ...
Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add ...
The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" ...
In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent ...
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...